Skip to content

Gross margin at other companies

Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
46.8%+2.5pp
Embecta Corp. logo
Embecta Corp.EMBC
61.9%-1.6pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
31.3%-1.4pp
InfuSystem Holdings logo
InfuSystem HoldingsINFU
56.7%+3.6pp
UFP Technologies logo
UFP TechnologiesUFPT
28.4%-0.6pp

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Calculated from KORU Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's gross margin?
KORU Medical Systems (KRMD) reported gross margin of 61.9% in Q1 2026.
How has KORU Medical Systems's gross margin changed year-over-year?
KORU Medical Systems's gross margin decreased by 2.5% year-over-year, from 63.5% to 61.9%.
What is the long-term trend for KORU Medical Systems's gross margin?
Over 5 years (2020 to 2025), KORU Medical Systems's gross margin has grown at a 0.2% compound annual growth rate (CAGR), from 61.8% to 62.3%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.